Report cover image

Flu Treatment Market Size-By Types, By Medication, By Route of Administration, By Distribution Channel, By End User-Regional Outlook, Competitive Strategies and Segment Forecast to 2032

Publisher SPER Market Research Pvt. Ltd.
Published Feb 09, 2023
Length 255 Pages
SKU # SPER18038246

Description

Flu Treatment Market Size-By Types, By Medication, By Route of Administration, By Distribution Channel, By End User-Regional Outlook, Competitive Strategies and Segment Forecast to 2032


Global Flu Treatment Market Overview

According to SPER Market Research, the Global Flu Treatment Market is estimated to reach USD 1.74 billion by 2032 with a CAGR of 5.25%. Flu, commonly known as influenza, is a typical viral infection. Chills, aches in the muscles, fever, headaches, runny nose, cough, and others are common flu symptoms. The respiratory tract is primarily impacted by flu. Influenza viruses come in four main categories: influenza A, influenza B, influenza C, and influenza D. The influenza virus types A and B that cause seasonal flu most frequently each year are A and B.

Impact of COVID-19 on the Global Flu Treatment Market

The global market for flu medications is expanding as a result of ongoing advancements in technology and partnerships between private businesses and governmental agencies for the treatment of such pandemic flu. This is due to the Covid-19 disease, which is spreading continuously throughout the world and causing a significant number of deaths worldwide.

Scope of the Report:

Report Metric Details
Market size available for years 2019-2032
Base year considered 2021
Forecast period 2022-2032

Segments covered By Type, By Medication, By Route of Administration, By Distribution Channel, By End User.

Regions covered Asia-Pacific, Europe, Middle East and Africa, North America, Latin America

Companies Covered AstraZeneca, Bayer AG, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., GSK plc, Lilly, Merck & Co. Inc., Mylan N.V., NATCO Pharma Limited.

Global Flu Treatment Market Segmentation:

By Medication: Based on the Medication, Global Flu Treatment Market is segmented as; Antiviral drugs, Antihistamines, Analgesics, and Others.

By Distribution Channel: Based on the Distribution Channel, Global Flu Treatment Market is segmented as; Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

By End User: Based on the End User, Global Flu Treatment Market is segmented as; Hospitals, Homecare, Specialty Clinics, Others

Table of Contents

255 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2. COVID-19 Impacts of the Global Flu Treatment Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats
5.2. PESTEL analysis
5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape
5.2.4 Technological landscape
5.2.5 Environmental landscape
5.2.6 Legal landscape
5.3. PORTER’S five forces analysis
5.3.1 Bargaining power of suppliers
5.3.2 Bargaining power of Buyers
5.3.3 Threat of Substitute
5.3.4 Threat of new entrant
5.3.5 Competitive rivalry
5.4. Heat map analysis
6. Competitive Landscape
6.1 Global Flu Treatment Manufacturing Base Distribution, Sales Area, Product Type
6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Flu Treatment Market
7. Global Flu Treatment Market, By Type, 2019-2032 (USD Million)
7.1. Type A
7.2. Type B
7.3. Type C
8. Global Flu Treatment Market, By Medication, 2019-2032 (USD Million)
8.1. Antiviral drugs
8.2. Antihistamines
8.3. Analgesics
8.4. Others
9. Global Flu Treatment Market, By Route of Administration, 2019-2032 (USD Million)
9.1. Oral
9.2. Parenteral
9.3. Others
10. Global Flu Treatment Market, By Distribution Channel, 2019-2032 (USD Million)
10.1. Hospital Pharmacy
10.2. Online Pharmacy
10.3. Retail Pharmacy
11. Global Flu Treatment Market, By End User, 2019-2032 (USD Million)
11.1. Hospitals
11.2. Homecare
11.3. Specialty Clinics
11.4. Others
12. Global Flu Treatment Market, By Region, 2019-2032 (USD Million)
12.1. Global Flu Treatment Market Size and Market Share by Region (2019-2025)
12.2. Global Flu Treatment Market Size and Market Share by Region (2026-2032)
12.3. Asia-Pacific
12.3.1. Australia
12.3.2. China
12.3.3. India
12.3.4. Japan
12.3.5. South Korea
12.3.6. Rest of Asia-Pacific
12.4. Europe
12.4.1. France
12.4.2. Germany
12.4.3. Italy
12.4.4. Spain
12.4.5. United Kingdom
12.4.6. Rest of Europe
12.5. Middle East and Africa
12.5.1. Kingdom of Saudi Arabia
12.5.2. United Arab Emirates
12.5.3. Rest of Middle East & Africa
12.6. North America
12.6.1. Canada
12.6.2. Mexico
12.6.3. United States
12.7. Latin America
12.7.1. Argentina
12.7.2. Brazil
12.7.3. Rest of Latin America
13. Company Profiles
13.1. AstraZeneca
13.1.1. Company details
13.1.2. Financial outlook
13.1.3. Product summary
13.1.4. Recent developments
13.2. Bayer AG
13.2.1. Company details
13.2.2. Financial outlook
13.2.3. Product summary
13.2.4. Recent developments
13.3. Bristol-Myers Squibb Company
13.3.1. Company details
13.3.2. Financial outlook
13.3.3. Product summary
13.3.4. Recent developments
13.4. F. Hoffmann-La Roche Ltd.
13.4.1. Company details
13.4.2. Financial outlook
13.4.3. Product summary
13.4.4. Recent developments
13.5. GSK plc
13.5.1. Company details
13.5.2. Financial outlook
13.5.3. Product summary
13.5.4. Recent developments
13.6. Lilly
13.6.1. Company details
13.6.2. Financial outlook
13.6.3. Product summary
13.6.4. Recent developments
13.7. Merck & Co. Inc.
13.7.1. Company details
13.7.2. Financial outlook
13.7.3. Product summary
13.7.4. Recent developments
13.8. Mylan N.V.
13.8.1. Company details
13.8.2. Financial outlook
13.8.3. Product summary
13.8.4. Recent developments
13.9. NATCO Pharma Limited
13.9.1. Company details
13.9.2. Financial outlook
13.9.3. Product summary
13.9.4. Recent developments
13.10. Novartis AG
13.10.1. Company details
13.10.2. Financial outlook
13.10.3. Product summary
13.10.4. Recent developments
13.11. Pfizer Inc.
13.11.1. Company details
13.11.2. Financial outlook
13.11.3. Product summary
13.11.4. Recent developments
13.12. Sanofi
13.12.1. Company details
13.12.2. Financial outlook
13.12.3. Product summary
13.12.4. Recent developments
13.13. Sun Pharmaceutical Industries Ltd.
13.13.1. Company details
13.13.2. Financial outlook
13.13.3. Product summary
13.13.4. Recent developments
14. List of Abbreviations
15. Reference Links
16. Conclusion
17. Research Scope

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us